Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JAYTHARI safely and effectively. See full prescribing information for JAYTHARI JAYTHARI (deflazacort) tablets, for oral use Initial U.S. Approval:2017
Medication labelWhy this: Advisory · dailymed-prescription
JAYTHARI is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
- generic_name
- deflazacort
- product_names
- Deflazacort
- ndc
- 70710-1749, 70710-1750, 70710-1751, 70710-1752, 70710-1749-1, 70710-1750-3, 70710-1751-3, 70710-1752-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en